Registration 333-283019
S-4/A · 2025-08-12 · 0001193125-25-178821
Terms from the governing filing for this registration; not a claim that the offering is open today.
Company research
Semnur, Inc.
CIK 1584541Updated Oct 6, 2026
Name history
Semnur Pharmaceuticals, Inc. · through Aug 13, 2025
Filing activity
Latest filing
22 filings on record · SCHEDULE 13D, 424B3, EFFECT, S-4/A, CORRESP, UPLOAD.
Offerings
Registration 333-283019
Registration 333-283019-01
Filing attachments
d887184dex991.htm · S-4/A · 2025-04-21
EX-99.1 21 d887184dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 CONSENT TO REFERENCE IN PROXY STATEMENT/PROSPECTUS October 17, 2024 Denali Capital Acquisition Corp. 437 Madison Avenue, 27th Floor New York, New York 10022 Denali Capital Acquisition Corp. (the “Company”) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 o…
Read attachment ↗d887184dex992.htm · S-4/A · 2025-04-21
EX-99.2 22 d887184dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 CONSENT TO REFERENCE IN PROXY STATEMENT/PROSPECTUS October 17, 2024 Denali Capital Acquisition Corp. 437 Madison Avenue, 27th Floor New York, New York 10022 Denali Capital Acquisition Corp. (the “Company”) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 o…
Read attachment ↗